CJC-1295 (without DAC) Dosage Guide, Benefits & Side Effects

CJC-1295 (without DAC) Dosage Guide, Benefits & Side Effects

CJC-1295 without DAC triggers short, sharp GH pulses that mimic natural secretion, boosting IGF-1, sleep quality, and recovery. See dosing.

Chemical Makeup

29

Amino Acids

CJC-1295 (without DAC)

Tyr

Position 1

Ala

Position 2

Asp

Position 3

Position 4

?

Position 5

Phe

Position 6

Position 7

Gln

Position 8

Ser

Position 9

Position 10

Arg

Position 11

Lys

Position 12

Val

Position 13

Leu

Position 14

Position 15

Position 16

Position 17

Position 18

Position 19

Position 20

Position 21

Position 22

Position 23

Position 24

Position 25

Position 26

Position 27

Position 28

Position 29

As seen on

CJC-1295 (without DAC) Dosage Guide for Fat Loss / MuscleCJC-1295 (without DAC) Dosage Calculator

CJC-1295 without DAC is a shorter-acting peptide that triggers quick pulses of growth hormone release.

Vial size

10 mg

Bacteriostatic water

3 mL

Dosing

100–250 mcg

Frequency

5 days on / 2 days off

Cycle

8–12 weeks

Benefit

Fat Loss / Muscle

What is CJC-1295 (without DAC)?

CJC-1295 (without DAC) is a lab-made peptide that mimics a natural hormone (GHRH) which tells your pituitary gland to release growth hormone. It's designed to resist breaking down quickly in the body, so it produces a more natural, pulse-like release of growth hormone rather than a sudden spike. It's commonly used in research focused on muscle building, fat loss, and recovery, often paired with another peptide like Ipamorelin.

Weight

Research targets include appetite regulation, fat metabolism, and body composition.

Growth

Research targets include growth hormone signaling, IGF-1 pathways, and tissue development.

cjc

Is CJC-1295 (without DAC) FDA approved?

CJC-1295 (without DAC) is not an FDA-approved drug. It is intended for research purposes only and is not approved for human consumption, diagnostic, or therapeutic use.

Research Use Only

CJC-1295 (without DAC) has not been evaluated by the FDA for safety or efficacy in humans.

No Clinical Oversight

Not manufactured under FDA-regulated quality or clinical standards.

Unregulated Sourcing

Purity, dosing, and sourcing are not verified through FDA testing or oversight.

Our top-rated vendor

View all vendors

Our rankings are based solely on third-party lab testing rigor, COA transparency, and pricing — no paid placements, no affiliate influence. We update this list as new data comes in.

Based on current scores, this vendor ranks highest across those criteria.

Protide Health

#1 Rated Research Peptide Supplier

How Does CJC-1295 (without DAC) Work?

It attaches to the same receptor in the pituitary gland that a natural hormone (GHRH) uses, triggering the release of growth hormone in the body's normal, pulsing pattern. Small changes to its structure make it much harder for the body to break down quickly, so it stays active longer than the natural hormone.

Mimics a natural hormone

Binds the same pituitary receptor as GHRH.

Triggers GH release

Prompts growth hormone release in the body's normal pulsing pattern.

Resists breakdown

Structural tweaks help it stay active far longer than the natural hormone.

CJC-1295 (without DAC) Targeted areas

How to reconstitute CJC-1295 (without DAC)

The materials you'll need and step-by-step instructions for safely mixing CJC-1295 (without DAC) with bacteriostatic water.

Materials needed

Your CJC-1295 (without DAC) vial (lyophilized)

Alcohol swabs

Bacteriostatic sterile water

3 mL syringes (Luer Lock tip)

25G or 27G needles (Luer Lock). Other gauges may also be acceptable.

Sharps container (optional)

Remove the caps

Sanitize the rubber stoppers

Attach the needle

Draw the bac water

Pull back on the plunger to draw your desired volume of bacteriostatic water. If you overfill, just push the excess back in until you reach the right marker on the syringe.

Insert the needle into the CJC-1295 (without DAC) vial

With the bac water in your syringe, insert the needle into the CJC-1295 (without DAC) vial at a slight angle to avoid pressure buildup.

Release the water gently

Let the water run gently down the side of the vial. Don't inject it forcefully.

Swirl to dissolve

Avoid shaking. Gently swirl, flip, and roll the vial to dissolve the powder.

Check for full dissolution

Cap, dispose, and store

How to Store CJC-1295 (without DAC)

Freeze the dry powder for up to 2–3 years. Once mixed with liquid, keep it in the fridge and use within about a month, and don't freeze it again after mixing.

Lyophilized Storage

-20°C, stable for 24–36 months.

Reconstituted Storage

With bacteriostatic water, 2–8°C for up to 28 days.

Handling Notes

Do not freeze the reconstituted solution.

What Are the Benefits of CJC-1295 (without DAC)?

What research says it may help with, and how it works in the body.

growth hormone

Helps restore the body's natural rhythm of growth hormone release in older adults, whose release patterns tend to flatten with age.

Supports the gland system that controls hormone release without shutting down the body's own natural hormone production.

Raises levels of a hormone called IGF-1 by boosting the body's own release of growth hormone.

antiaging

Helps preserve lean muscle by raising growth hormone levels.

Supports bone health by working through the same pathways that growth hormone uses.

Improves skin quality by boosting the body's production of collagen, the protein that keeps skin firm and elastic.

recovery

Speeds up recovery after exercise by raising growth hormone levels.

Improves the structure and quality of sleep when taken before bed.

What Are the Side Effects of CJC-1295 (without DAC)?

Who should avoid it, warning signs to watch for, and what to know before combining it with other compounds.

Who Should Avoid It

Active cancer (due to growth-promoting effects)

Diabetic retinopathy

Severe kidney disease

Pregnancy or breastfeeding

Stop Right Away If You Notice

Persistent joint pain or carpal tunnel symptoms

Significant water retention or edema

Unexplained headaches or vision changes

Extreme fatigue or lethargy

Allergic reaction signs at injection sites

Milder Signs to Watch For

Peptides Commonly Stacked With CJC-1295 (without DAC)

Peptides that are commonly stacked with CJC-1295 (without DAC), and the blends that combine them.

cjci

CJC-1295/Ipamorelin Blend (CJC-1295 (without DAC), Ipamorelin)

Experimental

How Long Should a CJC-1295 (without DAC) Cycle Last?

This breaks down how long a typical CJC-1295 (without DAC) cycle runs and what research suggests happens at each stage. Research shows that staying on a peptide continuously, without a break, may make it less effective over time.

That's why most research protocols build in a break between cycles, often called a washout period, to let the body reset before starting again.

Related peptides

tes

Metabolic

Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin)

Phase 3

5am

Longevity

5-Amino-1MQ

Preclinical

aod

AOD-9604

adi

Adipotide

Phase 1

Cheat Sheets Featuring CJC-1295 (without DAC)

See how CJC-1295 (without DAC) fits into a broader research stack with these free downloadable cheat sheets. Each one includes reference dose ranges, dosing frequency, and half-life for every peptide it covers. For research purposes only.

13 peptides

78 peptides

19 peptides

Browse user-created protocols

Real protocols from the community that include CJC-1295 (without DAC)

BPC157 ,GHKCU,RT20, MOTSC

N

Healing

ghk

bpc

Performance stack

jake

GLP-3

CJC-1295 (without DAC) Research References

It is a phase 2 compound

CJC-1295 (without DAC) is a phase 2 compound

In vitro and human receptor binding assays showed 4x greater receptor affinity than native GHRH with enhanced enzymatic degradation resistance.

2010

Frequently Asked Questions About CJC-1295 (without DAC)

Straight answers on reconstitution, dosing, and safety, everything you need to research with confidence. For research reference only.

What is CJC-1295 without DAC, and how is it different from CJC-1295 with DAC?

CJC-1295 without DAC, also called Mod GRF 1-29, is a modified growth-hormone-releasing hormone (GHRH) analog covering the first 29 amino acids of GHRH with stabilizing substitutions. It shares the same core sequence as CJC-1295 with DAC, but lacks the Drug Affinity Complex (DAC) — a modification that binds serum albumin and extends half-life to several days. Without DAC, the peptide has a short half-life of roughly 30 minutes to a couple of hours, producing a brief, pulsatile burst of GH release rather than the sustained, steady elevation seen with the DAC version. Because of this short half-life, no-DAC formulations require much more frequent dosing (often once to three times daily) compared to the once-weekly dosing common with DAC versions.

What is the typical research dosage for CJC-1295 without DAC?

Commonly discussed research protocols use 100–300 mcg per injection, administered subcutaneously one to three times per day (e.g., morning, post-workout, and/or before bed). Many sources describe roughly 100 mcg as an effective 'saturation dose' at the GHRH receptor, meaning higher single doses may not proportionally increase GH release, though repeated dosing throughout the day is used to create multiple GH pulses. Doses are typically given on an empty stomach, since food (especially carbohydrates or elevated blood glucose) can blunt the GH response. These figures reflect common practice reported by vendors and research communities, not an approved clinical dosing standard.

Why is CJC-1295 without DAC often paired with ipamorelin or other GHRPs?

CJC-1295 without DAC acts on GHRH receptors, while ipamorelin and similar growth-hormone-releasing peptides (GHRPs) act on ghrelin receptors (GHS-R1a) on the same pituitary cells. Because these are separate receptor pathways, using both together is reported to produce a substantially larger GH pulse than either compound alone. The two peptides' half-lives are also similar (roughly 30 minutes to 2 hours), which keeps the combined release pattern pulsatile rather than sustained, mimicking the timing of natural GH secretion more closely than a mismatched pairing would.

What side effects are commonly reported with CJC-1295 without DAC?

Commonly reported effects include injection-site redness, itching or irritation, transient flushing or warmth, mild headache, and water retention or joint puffiness related to elevated GH/IGF-1. Some users also report temporary lightheadedness or a 'tingly' sensation shortly after injection. Because it raises GH and downstream IGF-1, there is potential for effects on blood glucose regulation, so people with blood sugar sensitivities are frequently advised (in third-party sources) to monitor this. These reports come from vendor materials and user/forum discussion rather than controlled clinical trials, and formal human safety data for this specific formulation is limited.

How should CJC-1295 without DAC be stored and reconstituted?

The lyophilized (freeze-dried) powder is generally recommended to be stored frozen or refrigerated before reconstitution, protected from light. It is typically reconstituted with bacteriostatic water, and once mixed, is commonly stored refrigerated and reported to remain stable for roughly 2–4 weeks, though potency can gradually decline over time. A frequently cited practical setup is a 10 mg vial mixed with 3 mL of bacteriostatic water, yielding about 3,333 mcg/mL, so that 100 mcg equals about 3 units and 300 mcg equals about 9 units on a standard U-100 insulin syringe. Exact stability windows vary by source and are not independently standardized.

Is CJC-1295 without DAC legal to buy and use?

In the United States, CJC-1295 without DAC is not FDA-approved for human use. It is widely sold by suppliers labeled strictly for laboratory research purposes, not for human consumption, veterinary use, or clinical application. Purchasing and possessing it for genuine research through such suppliers is generally treated as legal, but using it for personal/human administration falls into a regulatory gray area and may carry legal risk depending on jurisdiction and how it is obtained or administered (e.g., through a licensed prescriber and compounding pharmacy versus an unregulated research-chemical vendor). It is also banned in competitive sport, listed under WADA's S2 category of prohibited peptide hormones and growth factors.

Why does CJC-1295 without DAC need to be dosed more often than the DAC version?

Its short plasma half-life (approximately 30 minutes) means blood levels drop quickly after each injection, so a single dose only produces one brief pulse of GHRH receptor stimulation. To generate multiple GH pulses across the day — which is intended to more closely resemble the body's natural GH secretion rhythm — it is typically injected multiple times daily (e.g., morning, around exercise, and before sleep). The DAC-modified version, by contrast, binds to serum albumin and stays in circulation for days, allowing far less frequent (often weekly) dosing but producing a more constant, non-pulsatile elevation instead.

What is the best time of day to inject CJC-1295 without DAC?

A commonly cited timing approach is to inject in a fasted state — at least 1–2 hours after eating and preferably with elevated blood sugar avoided — since insulin and food intake can dampen GHRH-stimulated GH release. Popular timing windows discussed in vendor and community sources include first thing in the morning, immediately post-workout, and roughly 30 minutes before bed, the last of which is intended to amplify the natural nocturnal GH surge that occurs during early deep sleep. These are practices reported in non-clinical sources rather than an established medical protocol.